Does magnesium help with muscle recovery?

Possibly for soreness, and not for strength. A 2024 systematic review found only 4 small studies of magnesium on muscle soreness in active people, 73 young people in all, 60 of them men, and read them as lowering soreness and muscle damage without pooling a number. A meta-analysis of 14 randomized trials found no significant gain in muscle strength, power or peak torque, and its authors saw no benefit in most athletes.

Unsettled. The soreness answer is open because the evidence is tiny and uneven. The largest placebo-controlled study in that review had 22 people, two of the four had no placebo group, and none tested older adults. A magnesium gel, the one randomized trial of a rub, found no benefit.

Established. For strength and power, the pooled trials show no gain. Across the 14-trial meta-analysis, magnesium did not raise muscle strength (weighted mean difference 0.87, 95% CI -0.12 to 1.86) or peak torque (0.87, 95% CI -1.43 to 3.18). The authors say most athletes already have a relatively high magnesium status.

What the trials found

Soreness after hard exercise

In 22 college students, 350 mg of magnesium a day for 10 days lowered soreness after eccentric bench press by about 1 to 2 points on a 6-point scale at 24, 36 and 48 hours, with no change on placebo. The abstract does not say the groups were randomized, the comparison was against each group's own starting point, and the gain in repetitions was not significant.

In 9 male runners on a low-magnesium diet, 500 mg a day for a week before a 10 km downhill run eased soreness and lowered the inflammatory marker IL-6. It did not speed the recovery of muscle force or lower creatine kinase, a marker of muscle damage. The diet was made low in magnesium on purpose, so the effect may reflect correcting a shortfall the runners were given.

In 12 elite basketball players taking 400 mg of magnesium lactate a day across a season, muscle damage markers stayed flat, and the authors read that as protection. The comparison group was 12 recreational players without a supplement and with no placebo, so stable markers cannot be credited to magnesium.

Unsettled. Magnesium gel on sore muscles has been tested in one randomized trial, and it found no benefit. In a randomized double-blind trial of 35 active adults, gel rubbed on the thighs around 40 minutes of downhill running did not reduce soreness, creatine kinase or IL-6 against a placebo gel. The authors note the dose in that one commercial gel may have been too low.

Strength and performance

The 14-trial meta-analysis included athletes, active people, untrained adults, older adults and people with alcoholism. Its authors concluded that magnesium may help muscles in people low in magnesium, such as older adults and people with alcoholism, and not in most athletes. An older review of 12 experimental studies, a narrative critique with no pooling, reached the same place: most evidence showed no effect on strength, anaerobic or aerobic performance.

Cramps

A Cochrane review found no randomized trial of magnesium for cramps linked to exercise. For leg cramps in non-pregnant adults, a 2026 meta-analysis of 4 trials found 0.42 fewer cramps a week (95% CI -1.15 to 0.31), not significant. A Cochrane review of 5 trials in 307 older adults with night cramps found 0.18 fewer a week (95% CI -0.84 to 0.49), on moderate-certainty evidence. The only signal for less muscle pain in the 2026 review came from one trial around surgery, not from exercise.

Who should be careful

Not for everyone. The doses in the soreness studies, 350 to 500 mg a day, sit at or above the NIH upper limit for magnesium from supplements, 350 mg a day for adults. High doses can cause diarrhea, nausea and cramping. NIH names carbonate, chloride, gluconate and oxide as the forms most often reported to cause diarrhea, and oxide was the form in the 9-runner trial.

In the cramp trials, minor side effects, almost all in the gut, were more common on magnesium, with a risk ratio of 1.51 (95% CI 0.98 to 2.33) on low-certainty evidence from 4 trials in 254 people. Serious events were no different, 2 of 72 people on magnesium against 3 of 68 on placebo.

If your kidneys work poorly, NIH warns that the risk of magnesium toxicity rises because the excess is no longer cleared. In one trial of 148 people with chronic kidney disease given magnesium hydroxide at a dose roughly double any ordinary supplement, 35 on magnesium had gut problems against 9 on placebo. There were 5 deaths and 6 heart or blood vessel events on magnesium against 2 deaths and none on placebo, small counts that were not the trial's main outcome.

Extra magnesium may not be neutral for people who already have enough. In 15 regular exercisers, 600 mg a day of magnesium chloride for 9 days, above the upper limit, slightly lowered cycling performance, and the authors advise exercisers without low blood magnesium not to supplement.

For children and teenagers the NIH upper limit for supplemental magnesium is lower, 65 to 350 mg a day depending on age.

We found no evidence on magnesium for muscle recovery in pregnancy, in children or teenagers who train, or alongside specific medicines. That is missing evidence, not a reassurance.

What expert bodies say

The EU allows magnesium to be labeled as contributing to normal muscle function. That claim rests on avoiding a shortfall and does not say extra magnesium speeds recovery. The NIH fact sheet on magnesium sets the upper limit above and has no section on exercise recovery.

How we searched

What would change this answer

• A randomized, placebo-controlled trial of oral magnesium for soreness large enough to matter. The largest placebo-controlled oral study so far had 22 people, and we found no such trial registered on ClinicalTrials.gov.
• A trial in people who train and have measured low magnesium, set against people who do not. The 14-trial meta-analysis points to the effect living there, and the soreness studies did not select for it.
• Studies in women and older adults. The soreness evidence is 60 men and 13 women aged 19 to 27.
• Any randomized trial of magnesium for cramps linked to exercise. A Cochrane review found none.

Sources

1. ev-mgrec-01 · Meta-analysis or systematic review · systematic review (PRISMA, PROSPERO CRD42024501822) of magnesium-only supplementation trials · n = 4 studies, 73 participants
   These studies showed that MgS reduced muscle soreness, improved performance, recovery and induced a protective effect on muscle damage.
   
   Who: physically active individuals and athletes aged 19-27 years
   Effect: reduced muscle soreness, better perceived recovery and lower muscle damage markers reported; no pooled effect size
   Certainty: No meta-analysis; 4 studies, 73 people; two of the four had no placebo group (basketball season, cyclists vs no supplement); dose and form vary.
   J Transl Med, 2024 · checked 2026-10-07 · we read the abstract
2. ev-mgrec-02 · Meta-analysis or systematic review · systematic review (PRISMA, PROSPERO CRD42024501822) of magnesium-only supplementation trials · n = 4 studies, 73 participants
   The four eligible studies consisted of 73 participants (60 males and 13 females) between 19–27 years old.
   
   Who: physically active individuals and athletes aged 19-27 years
   Effect: 4 studies, 73 participants (60 male, 13 female), aged 19-27
   Certainty: Shows the size of the gap: no trial in older adults, no placebo-controlled study with more than 22 people.
   J Transl Med, 2024 · checked 2026-10-07 · we read the fulltext
3. ev-mgrec-03 · Meta-analysis or systematic review · meta-analysis and systematic review of randomized clinical trials · n = 14 RCTs, 542 participants
   The results of the meta-analysis suggested that no significant improvements in the supplementation group were observed regarding isokinetic peak torque extension [WMD = 0.87; 95% CI = (-1.43, 3.18)], muscle strength [WMD = 0.87; 95% CI = (-0.12, 1.86)] or muscle power [WMD = 3.28; 95% CI = (-14.94, 21.50)].
   
   Who: athletes or physically active individuals, untrained healthy individuals, elderly or alcoholics
   Effect: peak torque WMD 0.87 (95% CI -1.43 to 3.18); muscle strength WMD 0.87 (-0.12 to 1.86); muscle power WMD 3.28 (-14.94 to 21.50)
   Certainty: Fixed-effect model; outcome is muscle function, not soreness; searched to July 2017.
   Magnes Res, 2017 · checked 2026-10-07 · we read the abstract
4. ev-mgrec-04 · Meta-analysis or systematic review · meta-analysis and systematic review of randomized clinical trials · n = 14 RCTs, 542 participants
   Evidence does not support a beneficial effect of Mg supplementation on muscle fitness in most athletes and physically active individuals who have a relatively high Mg status. But Mg supplementation may benefit individuals with Mg deficiency, such as the elderly and alcoholics.
   
   Who: athletes or physically active individuals, untrained healthy individuals, elderly or alcoholics
   Effect: no beneficial effect in most athletes and active people with a relatively high Mg status; possible benefit with Mg deficiency (elderly, alcoholics)
   Certainty: Subgroup interpretation by the authors; deficiency not measured directly in all trials.
   Magnes Res, 2017 · checked 2026-10-07 · we read the abstract
5. ev-mgrec-05 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized or quasi-randomized trials (PROSPERO CRD420251120631) · n = 13 trials (10 magnesium RCTs)
   In nocturnal or persistent leg cramps in adults (4 trials, N≈396), no significant effect was found (MD -0.42 cramps/week, 95% CI: -1.15 to 0.31, P = .26). Intravenous magnesium showed no benefit in older adults, but a perioperative trial demonstrated reduced fasciculations and postoperative myalgia.
   
   Who: adults with muscle cramps or myalgia in trials of electrolyte supplementation
   Effect: nocturnal or persistent leg cramps MD -0.42 cramps/week (95% CI -1.15 to 0.31), 4 trials, about 396 people; IV magnesium no benefit in older adults; one perioperative trial with less postoperative myalgia
   Certainty: No exercise-recovery trial in the pool; the myalgia signal comes from one perioperative trial, not from exercise.
   Int Dent J, 2026 · checked 2026-10-07 · we read the abstract
6. ev-mgrec-06 · Meta-analysis or systematic review · Cochrane systematic review of randomized trials · n = —
   We found no RCTs evaluating magnesium for exercise-associated muscle cramps or disease-state-associated muscle cramps (for example amyotrophic lateral sclerosis/motor neuron disease) other than a single small (inconclusive) study in people with liver cirrhosis, only some of whom suffered cramps.
   
   Who: people with exercise-associated or disease-state-associated muscle cramps
   Effect: no RCTs for exercise-associated cramps; one small inconclusive trial in liver cirrhosis
   Certainty: Absence of trials, searches to September 2019; none found in this 2026 pass either (ctgov_search empty).
   Cochrane Database Syst Rev, 2020 · checked 2026-10-07 · we read the abstract
7. ev-mgrec-07 · Observational data · double-blind, between-group placebo-controlled trial (randomization not stated in abstract) · n = 22
   Mg significantly reduced (∼1-2 units lower on a 6-point scale) muscle soreness from the baseline eccentric to postintervention trial 24, 36, and 48 hours with no significant change for placebo (Pla) group.
   
   Who: college-aged male (n = 9) and female (n = 13) subjects, 350 mg/day magnesium for 10 days
   Effect: soreness about 1-2 units lower (0-6 scale) at 24, 36 and 48 h vs baseline with magnesium, no change with placebo; repetitions to failure p = 0.06 (not significant)
   Certainty: Small, between-group comparison against baseline rather than direct group contrast; performance gain not significant; form named magnesium glycinate in the 2024 review.
   Journal of Strength and Conditioning Research, 2022, 36(8):2198-2203 (Reno et al.) · checked 2026-10-07 · we read the abstract
8. ev-mgrec-08 · Observational data · counterbalanced, double-blind, placebo-controlled crossover trial on a low magnesium diet · n = 9
   Magnesium supplementation reduced the IL-6 response, enhanced recovery of blood glucose, and muscle soreness after strenuous exercise, but did not improve performance or functional measures of recovery.
   
   Who: nine male recreational runners, 500 mg/day magnesium for 7 days before a 10 km downhill run
   Effect: lower IL-6 response and better recovery of muscle soreness; no improvement in performance or functional measures of recovery
   Certainty: Nine men, low-magnesium diet imposed beforehand, so the effect may reflect correcting a shortfall.
   Eur J Appl Physiol, 2019 · checked 2026-10-07 · we read the abstract
9. ev-mgrec-09 · Randomized controlled trial(s) · randomized, double-blind, parallel-design trial · n = 35
   The Mg gel did not reduce muscle soreness or muscle damage markers after unaccustomed exercise compared with Pla.
   
   Who: healthy active participants, magnesium or placebo gel on each thigh around 40 min downhill running
   Effect: no reduction in muscle soreness or muscle damage markers against placebo gel
   Certainty: One commercial gel at 0.53 mg/ml; authors note the dose or protocol may have been too low.
   Int J Sport Nutr Exerc Metab, 2025 · checked 2026-10-07 · we read the abstract
10. ev-mgrec-10 · Observational data · uncontrolled supplementation over a competitive season with a recreational comparison group · n = 24
    Levels of muscle damage parameters remained the same during the entire season (P > 0.05), except for creatinine, which significantly decreased after T2, and then increased significantly in T3 and T4 compared to T2.
    
    Who: twelve elite male basketball players on 400 mg/day magnesium lactate, twelve recreational controls
    Effect: muscle damage parameters unchanged across the season (P > 0.05), except creatinine
    Certainty: No placebo, controls were recreational players without supplement; stable markers cannot be credited to magnesium.
    Magnes Res, 2017 · checked 2026-10-07 · we read the abstract
11. ev-mgrec-11 · Position of an expert body · agency fact sheet · n = —
    The Tolerable Upper Intake Level for supplemental magnesium is 350 mg for adults, and it ranges from 65 to 350 mg for children and adolescents, depending on age.
    
    Who: adults; children and adolescents 65 to 350 mg depending on age
    Effect: UL 350 mg/day supplemental magnesium (adults); food magnesium not limited
    Certainty: The trial doses for soreness (350-500 mg/day) sit at or above this limit.
    NIH Office of Dietary Supplements, Magnesium fact sheet for health professionals · checked 2026-10-07 · we read the section
12. ev-mgrec-12 · Position of an expert body · agency fact sheet · n = —
    The forms of magnesium that are most commonly reported to cause diarrhea include magnesium carbonate, chloride, gluconate, and oxide [12].
    
    Who: people taking magnesium supplements
    Effect: diarrhea most often with carbonate, chloride, gluconate and oxide forms
    Certainty: Oxide was the form in the 9-runner trial.
    NIH Office of Dietary Supplements, Magnesium fact sheet for health professionals · checked 2026-10-07 · we read the section
13. ev-mgrec-13 · Position of an expert body · agency fact sheet · n = —
    The risk of magnesium toxicity increases with impaired renal function or kidney failure because the ability to remove excess magnesium is reduced or lost
    
    Who: people with impaired renal function or kidney failure
    Effect: higher risk of magnesium toxicity
    Certainty: General agency warning without a numeric threshold.
    NIH Office of Dietary Supplements, Magnesium fact sheet for health professionals · checked 2026-10-07 · we read the section
14. ev-mgrec-14 · Position of an expert body · entry in the EU Register on nutrition and health claims, authorized list · n = —
    POL-HC-6405 Magnesium Magnesium contributes to normal muscle function Authorised
    
    Who: EU food labeling
    Effect: claim POL-HC-6405 'Magnesium contributes to normal muscle function', status Authorised
    Certainty: Authorized function claims rest on avoiding deficiency, and do not show that extra magnesium speeds recovery; conditions of use in Regulation (EU) No 432/2012.
    EU Register on nutrition and health claims (European Commission), claim POL-HC-6405, snapshot 2026-09-21 · checked 2026-10-07 · we read the dataset
15. mg-t1 · Meta-analysis or systematic review · Cochrane systematic review and meta-analysis of randomized trials · n = 307 in the main comparison, 735 across the whole review
    the difference in the number of cramps per week at four weeks (MD -0.18 cramps/week, 95% CI -0.84 to 0.49; 5 studies, 307 participants; moderate-certainty evidence)
    
    Who: older adults with idiopathic night cramps, mean age 61.6 to 69.3 years, 5 trials
    Effect: number of cramps a week at four weeks, mean difference -0.18 (95% CI -0.84 to 0.49)
    Certainty: moderate-certainty evidence, little heterogeneity
    Garrison et al., Cochrane Database of Systematic Reviews, 2020 · checked 2026-09-16 · we read the abstract
16. mg-r6-01 · Meta-analysis or systematic review · Cochrane systematic review and meta-analysis of randomized controlled trials, pooling adverse events across all settings · n = 735 individuals in 11 trials; 254 participants in the 4 trials that reported minor adverse events, and 140 in the major-event analysis
    Major adverse events (occurring in 2 out of 72 magnesium recipients and 3 out of 68 placebo recipients), and withdrawals due to adverse events, were not significantly different from placebo. However, in the four studies for which it could be determined, more participants experienced minor adverse events in the magnesium group than in the placebo group (RR 1.51, 95% CI 0.98 to 2.33; 4 studies, 254 participants; low-certainty evidence).
    
    Who: people taking oral magnesium for skeletal muscle cramps: pregnant women, older adults and people with idiopathic cramps
    Effect: minor adverse events risk ratio 1.51 (95% CI 0.98 to 2.33); major adverse events in 2 of 72 magnesium recipients against 3 of 68 on placebo, no significant difference, and withdrawals for adverse events also no different
    Certainty: low-certainty evidence for the minor events, and the confidence interval touches 1.0; only four of eleven trials reported minor events at all
    Garrison et al., Cochrane Database of Systematic Reviews, 2020 · checked 2026-09-17 · we read the abstract
17. mg-r6-02 · Randomized controlled trial(s) · randomized, double-blinded, placebo-controlled parallel-group trial over 12 months · n = 148 randomized, 75 on magnesium and 73 on placebo
    Among subjects who experienced gastrointestinal adverse effects, 35 were in the group receiving magnesium treatment versus nine in the placebo group. Five deaths and six cardiovascular events occurred in the magnesium group compared with two deaths and no cardiovascular events in the placebo group.
    
    Who: patients with chronic kidney disease and an estimated filtration rate of 15 to 45 ml/min, given magnesium hydroxide 15 mmol twice daily
    Effect: gastrointestinal adverse effects in 35 people on magnesium against 9 on placebo; 5 deaths and 6 cardiovascular events on magnesium against 2 deaths and no cardiovascular events on placebo; coronary calcification unchanged
    Certainty: a single trial of 148 people and a dose of 30 mmol a day, roughly double any ordinary supplement; the death and event counts are small and were not the trial's primary outcome
    Bressendorff et al., Journal of the American Society of Nephrology, 2023 · checked 2026-09-17 · we read the abstract
18. ev-mgfat-04 · Randomized controlled trial(s) · systematic critique of experimental studies (Medline 1966-1999) · n = 12 studies
    CONCLUSIONS: Most evidence indicates no effect of Mg supplementation on performance (strength, anaerobic-lactacid, and aerobic).
    
    Who: athletes and active people in experimental magnesium supplementation studies, 116 to 500 mg a day for 1 day to 3 months
    Effect: strength of evidence favors no effect; untrained subjects may benefit more than trained (unconfirmed)
    Certainty: Old (to 1999), mixed designs, no meta-analysis, magnesium status rarely measured; females barely studied. Level B: a narrative critique of experimental studies, not a synthesis of RCTs.
    Clin J Sport Med, 2000 · checked 2026-10-06 · we read the abstract
19. ev-mgfat-10 · Randomized controlled trial(s) · randomized, double-blind, placebo-controlled crossover trial · n = 15
    Conclusions: In summary, magnesium supplementation had modest ergolytic effects on cycle ergometer exercise performance and mitochondrial respiration.
    
    Who: men and women who were regular exercisers, magnesium chloride 300 mg twice a day for 9 days vs placebo
    Effect: VO2max 44.4 vs 41.3 mL/kg/min (p = 0.005); 30 s sprint power 439 vs 415 W (p = 0.03); 10 km time trial unchanged
    Certainty: Tiny, very short; dose above the 350 mg supplemental UL. Authors advise exercisers without hypomagnesemia not to supplement.
    Nutrients, 2025 · checked 2026-10-06 · we read the abstract